Global Nuclear Medicine Equipment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Nuclear Medicine Equipment Market Size

• The global nuclear medicine equipment market size was valued at USD 2.76 billion in 2024 and is expected to reach USD 4.64 billion by 2032, at a CAGR of 6.70% during the forecast period
• This growth is driven by factors such as the advancements in technology, increasing applications in oncology, cardiology, and neurology, and the rising demand for early diagnosis and personalized treatment options

Nuclear Medicine Equipment Market Analysis

• Nuclear medicine equipment is essential for diagnosing and treating various diseases, utilizing small amounts of radioactive materials for imaging and therapeutic procedures, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans
• The demand for nuclear medicine equipment is primarily driven by advancements in imaging technologies, increasing cancer and cardiovascular disease prevalence, and the growing need for early diagnosis and precision medicine
• North America is expected to dominate the nuclear medicine equipment market with a market share of 35.5%, due to advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and a strong presence of leading manufacturers
• Asia-Pacific is expected to be the fastest growing region in the nuclear medicine equipment market with a market share of 20.5%, during the forecast period due to rapid advancements in healthcare infrastructure, increasing awareness of early diagnosis, and growing surgical volumes
• Single photon emission computed tomography (SPECT) segment is expected to dominate the market with a market share of 58.38% due to its cost-effectiveness, wide availability, and established clinical use. SPECT offers high-resolution imaging for a variety of conditions, including cardiovascular diseases, cancer, and neurological disorders

Report Scope and Nuclear Medicine Equipment Market Segmentation       

Nuclear Medicine Equipment Market Trends

“Advancements in Imaging Technologies & Precision Medicine for Early Diagnosis”

• A key trend in the evolution of nuclear medicine equipment is the increasing adoption of advanced imaging technologies such as PET and SPECT, coupled with the growing focus on precision medicine
• These innovations enhance diagnostic accuracy by providing high-resolution, molecular-level imaging, enabling early detection of diseases such as cancer, cardiovascular conditions, and neurological disorders 
  • For instance, PET imaging systems are evolving with enhanced sensitivity and faster scanning times, improving the detection of small tumors and abnormal tissue
• These advancements are revolutionizing early-stage disease diagnosis, personalized treatment planning, and therapy monitoring, thereby driving demand for more sophisticated nuclear medicine equipment with cutting-edge capabilities

Nuclear Medicine Equipment Market Dynamics

Driver

“Increasing Demand Due to Rising Prevalence of Chronic Disease”

• The growing prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and neurological disorders, is significantly driving the demand for nuclear medicine equipment
• As the global population ages and lifestyle-related diseases increase, the need for advanced diagnostic imaging technologies, such as PET and SPECT, has surged. These technologies are essential for early detection, precise diagnosis, and effective treatment planning
• As more patients seek accurate and personalized treatments, the demand for nuclear medicine equipment rises, enhancing diagnostic capabilities and improving patient outcomes

For instance,

• According to the World Health Organization, in 2021, cancer was one of the leading causes of death worldwide, contributing to an increased need for advanced imaging technologies to aid in early detection and staging of the disease 
• As a result, the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders is fueling the demand for nuclear medicine equipment, particularly for early diagnosis and personalized treatment approaches

Opportunity

“Advancing Imaging with Artificial Intelligence Integration”

• AI-powered nuclear medicine imaging systems are poised to enhance diagnostic capabilities by improving image quality, automating analysis, and providing real-time insights for better decision-making in clinical settings
• AI algorithms can analyze PET and SPECT images to detect abnormalities such as tumors, plaques, and other tissue irregularities with greater precision and speed, helping healthcare professionals identify potential issues early
• Moreover, AI integration can assist in automating the image interpretation process, improving consistency and accuracy while reducing the workload of medical professionals, allowing them to focus on patient care

For instance,

• In December 2024, according to an article published in The Lancet, AI models based on deep learning showed promise in analyzing PET scans for early-stage cancer detection, helping oncologists plan personalized treatment strategies based on precise, real-time data 
• The integration of AI in nuclear medicine imaging systems can lead to more accurate diagnostics, improved patient outcomes, and optimized treatment planning, ultimately enhancing the efficiency of the healthcare system and contributing to better disease management

Restraint/Challenge

“High Equipment Costs Hindering Market Penetration”

• The high cost of nuclear medicine equipment, particularly PET and SPECT scanners, remains a significant challenge for market growth, especially in low- and middle-income countries
• These advanced imaging systems, which are critical for diagnosing complex conditions such as cancer and cardiovascular diseases, can cost millions of dollars, making them inaccessible for many healthcare facilities, especially smaller hospitals and clinics
• This substantial financial burden associated with the purchase and maintenance of such equipment can prevent healthcare institutions from adopting newer technologies, leading to a reliance on older, less effective diagnostic tools

For instance,

• In October 2024, according to an article published by the Journal of Nuclear Medicine, the high cost of PET and SPECT scanners continues to be a major barrier for healthcare systems in developing countries, limiting the widespread availability of nuclear medicine services and hindering access to cutting-edge diagnostic procedures 
• Consequently, these financial constraints can lead to disparities in the quality of healthcare, limit access to advanced diagnostic technologies, and ultimately slow the overall adoption and expansion of nuclear medicine equipment in global markets

Nuclear Medicine Equipment Market Scope

The market is segmented on the basis of product type, application, and end user

In 2025, the single photon emission computed tomography (SPECT) is projected to dominate the market with a largest share in product type segment

The single photon emission computed tomography (SPECT) segment is expected to dominate the nuclear medicine equipment market with the largest share of 58.38% in 2025 due to its cost-effectiveness, wide availability, and established clinical use. SPECT offers high-resolution imaging for a variety of conditions, including cardiovascular diseases, cancer, and neurological disorders. Its versatility and ability to provide detailed functional information about organs contribute to its continued demand in diagnostic imaging

The oncology is expected to account for the largest share during the forecast period in application market

In 2025, the oncology segment is expected to dominate the market with the largest market share of 49.49% due to the increasing prevalence of cancer and the growing demand for early detection and precise treatment planning. Nuclear medicine technologies, such as PET and SPECT, offer detailed imaging that helps in tumor detection, staging, and monitoring therapy responses. These advancements are critical for improving patient outcomes and driving the adoption of nuclear imaging in oncology

Nuclear Medicine Equipment Market Regional Analysis

“North America Holds the Largest Share in the Nuclear Medicine Equipment Market”

• North America dominates the nuclear medicine equipment market with a market share of estimated 35.5%, driven by advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and a strong presence of leading manufacturers
• U.S. holds a market share of 40.5%, due to high demand for early-stage disease detection, particularly for oncology, cardiovascular diseases, and neurological disorders, along with continuous advancements in nuclear imaging technologies such as PET and SPECT
• The presence of well-established reimbursement policies, robust healthcare funding, and substantial investments in research and development by major medical device companies further strengthen the market position in this region
• In addition, the increasing number of diagnostic procedures, combined with rising demand for personalized medicine and precision diagnostics, is driving market growth across North America.

“Asia-Pacific is Projected to Register the Highest CAGR in the Nuclear Medicine Equipment Market”

• Asia-Pacific is expected to witness the highest growth rate in the nuclear medicine equipment market with a market share of 20.5%, driven by rapid advancements in healthcare infrastructure, increasing awareness of early diagnosis, and growing surgical volumes
• Countries such as China, India, and Japan are emerging as key markets, with a large patient pool suffering from chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. The rising demand for advanced diagnostic tools is contributing to significant market expansion
• Japan, with its technological advancements in medical imaging and a well-established healthcare system, continues to lead in the adoption of nuclear medicine equipment, particularly in the areas of oncology and cardiology
• India is projected to experience the highest CAGR in the nuclear medicine equipment market, fueled by expanding healthcare infrastructure, an increasing patient base for chronic diseases, and growing investments in advanced diagnostic technologies

Nuclear Medicine Equipment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Siemens Healthineers AG (Germany)
• GE HealthCare(U.S.)
• Koninklijke Philips N.V. (Netherlands)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Medtronic (Ireland)
• Eckert & Ziegler (Germany)
• Varian (U.S.)
• Shimadzu Corporation (Japan)
• Hitachi, Ltd. (Japan)
• Spectrum Dynamics Medical (U.S.)
• SPECT/CT Ltd. (Israel)
• Lantheus (U.S.)
• Cardinal Health (U.S.)
• Advanced Accelerator Applications (SA) (France)
• Bayer AG (Germany)
• TRASIS (Belgium)
• Molecular Imaging, Inc. (U.S.)
• Iba Molecular (Belgium)
• Nordion (Canada) Inc. (Canada)

Latest Developments in Global Nuclear Medicine Equipment Market

• In December 2024, Canon Medical Systems announced new enhancements to its Celesteion PET/CT system, including advanced acquisition and reconstruction techniques. These improvements aim to deliver faster and more accurate imaging for oncology and cardiology applications
• In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement to equip Mercurius Health’s Robert Janker Klinik cancer center in Bonn, Germany. Philips and Elekta will install advanced oncology diagnostic and therapeutic equipment, along with aligned informatics solutions, enhancing cancer care capabilities at the newly acquired facility
• In April 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based company specializing in Nuclear Medicine and Molecular Imaging equipment. This acquisition aims to bolster Mediso’s presence in the UK and Ireland markets, leveraging Bartec’s expertise in supply, installation, and support of medical imaging technologies
• In June 2022, Siemens Healthineers launched the Symbia Pro.specta, a SPECT/CT system with CE mark and FDA clearance. This advanced system integrates state-of-the-art SPECT and CT imaging technologies, featuring a low-dose CT capable of capturing detailed images with up to 64 slices, enhancing diagnostic accuracy and patient care
• In November 2022, Canon, Inc. announced the establishment of Canon Healthcare USA, INC., a new subsidiary aimed at expanding Canon’s footprint in the American medical market. This strategic move underscores Canon’s commitment to advancing its medical business through enhanced service offerings and innovative healthcare solutions in the U.S.

SKU-1580